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1. Introduction 
1.1 Summary 
The biochemistry of retroviral integration selectivity is not fully understood. We modified 
the previously reported in vitro integration reaction protocol and developed a novel reaction 
system with higher efficiency. We used a DNA target composed of a repeat sequence DNA, 
5’-(GTCCCTTCCCAGT)6(ACTGGGAAGGGAC) 6-3’, that was ligated into a circular 
plasmid. Target DNA was reacted with a pre-integration (PI) complex that was formed by 
incubation of the end cDNA of the HIV-1 genome and recombinant integrase. It was 
confirmed that integration selectively occurred in the middle segment of the repeat 
sequence. On the other hand, both frequency and selectivity of integration markedly 
decreased when target sequences were used in which CAGT bases in the middle position of 
the original target sequence were deleted. Moreover, upon incubation with a combination of 
these deleted DNAs and the original sequence, the integration efficiency and selectivity 
towards the original target sequence were significantly reduced, which indicated interference 
effects by the deleted sequence DNAs. Efficiency and selectivity were also found to vary with 
changes in the manganese dichloride concentration of the reaction buffer, probably due to 
induction of fluctuation in the secondary structure of the substrate DNA. Such fluctuation may 
generate structural isomers that are favorable for selective integration into the target sequence 
DNA. In conclusion, there is considerable selectivity in HIV-integration into the specified 
target sequence. The present in vitro integration system will therefore be useful for monitoring 
viral integration activity or for testing of integrase inhibitors. 
1.2 Background 
Retroviral integration into host DNA is a critical step in the viral life cycle. Once integrated, the 
proviral genome will be stably duplicated along with the host cellular DNA duplication and 
will be transmitted to the daughter cells. Retroviruses can thus serve as powerful tools for the 
integration of foreign genes into a host genome (Fig. 1), and an MLV vector can be used to 
examine the function of introduced genes and the development of induced pluripotent stem 
(iPS) cells [1]. However, integrated retroviral genomes also have the potential to cause 
unexpected transformation through up-regulation of target genes by retroviral promoter 
elements located at the long terminal repeat (LTR) following integration [2]. Although  
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Fig. 1. Scheme of viral integration into target DNA: 3’-processing, join reaction, and gap repair. 
After the HIV-1 RNA genome has been transcribed into double-stranded DNA, the viral 
protein integrase binds to the termini of the viral DNA ends in a tetrameric fashion and the 
integrase creates overlapping 5’-ends by removing two nucleotides from the 3’-ends (3’end-
processing). The HIV-1 DNA and the host cell DNA are ligated by synthesis of 
phosphodiester bonds between the terminal nucleotides of the viral 3’-ends and overlapping 
5’-ends of the host chromosome. The non-homologous 5’-ends from the viral DNA are 
removed by integrase. Finally, the gaps are filled up by host cellular repair proteins, which 
recognize single strand breaks. A five base-repeat is observed in the flanking sequence after 
the gap repair reaction. 
integration events have long been considered to be random, several recent findings have 
shown that integration of the murine leukemia retrovirus (MLV) and of HIV-1 is detected 
more frequently in actively transcribed genes [3, 4] or in promoter regions [5]. Previous 
statistical studies have also demonstrated that weak palindromic sequences are a common 
feature of the sites targeted for retroviral integration [6, 7]. Similar target preferences have 
also been reported for human T cell leukemia retrovirus type I (HTLV-I) integration sites [8]. 
Because of these findings, we investigated the biophysical mechanisms underlying in vitro 
integration. In the present study, we aimed to establish an in vitro integration assay using 
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retroviral cDNA and integrase. Yoshinaga et al. previously reported the development of an 
in vitro integration assay using recombinant HIV-1 integrase, and short viral and target 
DNA sequences [9]. Using this method, they successfully detected retroviral cDNA-target 
DNA complexes in vitro and reported that the dinucleotide motif 5’-CA that is located at the 
proviral genome termini was essential for HIV-1 integration. Yoshinaga et al. called these 
dinucleotides the integration signal sequence. We modified Yoshinaga’s method of in vitro 
integration in order to identify the precise HIV-1 integration sites using a target DNA that 
corresponds to an actual gene sequence. 
In our previous study, we identified a common MLV integration site within the signal 
transducer and activators of transcription 5a (Stat5a) gene in MLV-induced spontaneous murine 
lymphoma in an inbred strain of mice, SL/Kh [10]. This is the first report of MLV 
integration target sequence. It has also been previously demonstrated that the Stat5a gene 
represents one of the common integration sites of MLV (the Mouse Retrovirus Tagged 
Cancer Gene Database (MRTCGD) (http://rtcgd.ncifcrf.gov/cgi-bin/mm7/easy_search.cgi) 
[11]. The encoded STAT5A protein is a transcription factor that is known to play an essential 
role in the development of myelo- and lympho-proliferative disease [12, 13]. In the current 
study, we modified this Stat5a gene sequence for use as a target for HIV-1 integration in 
vitro. This target gene consists of a 5’-CA-rich sequence, which may provide a useful clue for 
preparation of target DNA sequences, because terminal CA dinucleotide motifs are shared 
by MLV and HIV-1, as well as by HTLV-I proviruses. 
2. In vitro integration assay used in previous studies 
In many previous in vitro integration protocols, the double stranded DNA of the HIV-1 3'-LTR 
proviral end alone and the substrate DNA are mixed in an appropriate buffer containing 
MnCl2 [14] (Fig. 2, 3). Subsequently, a PCR reaction using a primer set targeted to the proviral  
 
Fig. 2. Scheme of the previously described incubation with recombinant integrase 
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DNA and the target DNA amplifies a DNA segment that includes the viral-host DNA 
junction. In some protocols, even the viral DNA itself is used as the target DNA. Thus, 
previous studies paid little attention to the target sequence. It is commonly known that 
integrase binds to the proviral DNA in a regular tetrameric fashion. Indeed, some sequence 
motifs should be favored by an integrase oligomer, because a dimeric transcriptional factor 
protein has the ability to bind to palindromic sequence motifs such as E-box and GAS elements. 
The 3’ end of the HIV-1 LTR sequence is shown. Red letters indicate the conserved 
dinucleotide motif. Incubation of the 3’ end of the HIV-1 LTR sequence DNA with integrase 
results in processing of the end of the 5’-GT dinucleotide. The resulting exposed hydroxyl 
group then attacks the target DNA. 
 5’ AAAATCTAGCAGT -3’
 3’ TTTTAGATCGTCA -5’
Incubation with integrase
 5’ AAAATCTAGCA  -3’
 3’ TTTTAGATCGTCA-5’
3
5
5
3
Joining reaction
In vitro integration assay
Host DNA
+
 
Fig. 3. Protocol of the previously described in vitro integration assay 
A nick is introduced into the host DNA that is attached to a CA dinucleotide in the HIV-1 
DNA end. Red letters indicate the conserved dinucleotide motif. Arrows indicate the PCR 
primer set and the direction of DNA polymerization. 
2.1 Preparation of target sequences for in vitro integration 
We recently reported the target sequence of MLV integration. We developed an inbred 
strain of mice suffering from spontaneous B cell lymphoma by MLV integration. MLV 
integration into Stat5a was identified in 25% of the lymphoma genome [15, 16] (Fig. 4). As 
depicted in Fig. 4, the hot spot of integration included a 5’-CA-rich sequence as well as a 
palindromic motif. Downward facing arrows in the figure indicated the MLV integration 
sites. The abundance of 5’-CA dinucleotides in the integration hot spots provided us with a 
hint for the preparation of target DNA for HIV integration, because these motifs are shared 
by the genome ends of MLV and HIV-1 (Fig. 5). We hypothesized that HIV-1 DNA also 
favors such a 5’-CA-rich sequence motif. 
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GCAGTGGACACTGACATTATCACACTCCACTCGGAGCGG
Target sequence of MLV integration 
Exon 2 Exon 3
5’ 3’
Stat5a
 
Fig. 4. Target sequence of MLV integration within the Stat5a gene.  
Downward-facing arrows indicate the MLV integration sites (15, 16). Red letters highlight 
the CA-rich sequence. Blue boxes represent exons of the Stat5a gene. Underlines indicates 
the palindromic motif. 
 
Fig. 5. Conserved 5’-CA dinucleotide in the proviral ends of HIV-1 and MLV. 
A box indicate the integration signal sequence reported by Yoshinaga et al (9). 
2.2 Modified In vitro integration assay 
We then prepared a target sequence for HIV-1 integration. A repeat sequence was prepared 
in order to enhance integration efficiency. We used the repeat sequence, 5’-
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(GTCCCTTCCCAGT)6(ACTGGGAAGGGAC)6-3’, or a modification of this sequence, which 
was ligated into a circular plasmid. The sequence within parenthesis is the unit of the repeat. 
This target sequence includes the 5’-CA dinucleotide motif, and includes 5’-AC at the HIV-1 
DNA termini (Fig. 5). 5’-CAGT and 5’-ACTG (shown in italics in the above sequence) in the 
repeat units are also present in the HIV-1 proviral genome ends. This target DNA was 
reacted with recombinant integrase and formed a pre-integration (PI) complex. Figures 6 
and 7 show our scheme of in vitro integration as well as the sequences of the HIV-1 proviral 
5’- and 3’-ends. Following incubation of the proviral LTR sequence DNAs with recombinant 
integrase, the resultant pre-integration complexes were reacted with the target DNA. PCR 
amplification was performed and the integration sites were analyzed by direct sequencing. 
Unlike previously reported protocols, we used both 5’- and 3’-LTR sequences in our 
protocol. Such a target sequence unit was expected to directly interact with complementary 
HIV-1 DNA end sequences present in the target DNA. Complementarity between HIV-1 
DNA and host DNA is shown in Fig. 8. 
5’-TGTGTGCCCGTC--------------TGGAAAATCTCTAGCA  -3’
3’-ACACACGGGCAG--------------ACCTTTTAGAGATCGTCA-5’
5’-LTR 
HIV-1 DNA 
5’-ACTGGAAGGGTT--------------CAAGGCTACTTCCCA  -3’
3’-TGACCTTCCCAA--------------GTTCCGATGAAGGGTCA-5’
Target DNA 
Plasmid DNA 
HIV-1 DNA 
R Q S 
S 
Q 
R 
3’-LTR 
PCR product 
 
Fig. 6. Scheme of in vitro viral integration into the target sequence.  
The red segment in the target sequence DNA that includes a circular plasmid represents the 
144-bp target DNA, and the black line represents the remainder of the circular plasmid 
DNA used for ligation. Following incubation of the proviral LTR sequence DNAs with 
integrase, the resultant pre-integration complexes were reacted with the substrate DNA. 
Red letters in the HIV-1 cDNA represent the LTR termini. PCR amplification was performed 
using primers corresponding to regions in the proviral ends and a plasmid region. The 
integration sites were analyzed by direct sequencing. “Q” in the PCR product indicates the 
junction between the provirus and the target DNA and R&S represents the 3’-ends of the 
primer within the HIV-1 DNA and the plasmid DNA, respectively [14]. 
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+5 ----------------AAAATCTAGCA   -3
-3 ----------------TTTTAGATCGTCA -5
Joining reaction 
Modified In vitro integration assay with  
3  processed U5 and U3 LTR DNA 
target sequence DNA 
 5 -ACTGGAAAGGGTT-----------------3
 3 -  ACCTTTCCCAA-----------------5
Incubation with integrase Incubation with integrase 
+MnCl2 +MnCl2 
(5’GTGGAGGGCAGT-3’)6(5’ACTGCCCTCCAC3’)6
(3’CACCTCCCGTCA-5’)6(3’TGACGGGAGGTG5’)6
 
Fig. 7. Target sequence for integration.  
The top sequences show the termini of the HIV-1 provirus. The bottom sequence indicates 
the target sequence and highlights the dinucleotide motif CA/TG (red), and the AC bases 
(yellow) that are also present at the HIV-1 DNA termini. We prepared a repeat sequence in 
order to enhance integration efficiency. The sequence shown in parenthesis is the unit of the 
repeat. Our protocol differs from previous protocols in that we used both 5’- and 3’-LTR 
sequences rather than a single 3’-LTR DNA. 
   (5’-GTGGAGGGCAGT)
 
(ACTGCCCTCCAC-3’)
 
(3’-CACCTCCCGTCA) (TGACGGGAGGTG-5’)
+5 ----------------AAAATCTAGCA   -3
-3 ----------------TTTTAGATCGTCA -5
+5 -ACTGGAAAGGGTT-----------------3
-3 -  ACCTTT CCCAA----------------5
Target sequence
 
Fig. 8. Integration scheme.  
The repeat sequence unit in the target sequence was expected to directly interact with HIV-1 
DNA. The dotted lines indicate complementarity between target and viral DNA. The 
dsDNA sequence at the bottom indicates the 5’- and 3’-ends of the proviral HIV-1 DNA. 
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2.3 Reaction protocol 
The detailed reaction protocol that we used is as follows. First, 75 ng of the U5’-LTR cDNA 
sequence of HIV-1.; (+) 5’-TGT GTG CCC GTC TGT TGT GTG ACT CTG GTA ACT AGA 
GAT CCT CAG ACC TTT TTG GTA GTG TGG AAA ATC TCT AGC A-3’ and (-) 5’-ACT 
GCT AGA GAT TTT CCA CAC TAC CAA AAA GGG TCT GAG GGA TCT CTA GTT ACC 
AGA GTC ACA CAA CAG ACG GGC ACA CA-3’, was incubated with 50 ng recombinant 
HIV-1 integrase in 10 l of binding buffer for 1 h at 30°C. The binding buffer consisted of 1-
0.1 mM MnCl2, 80 mM glutamate potassium glutamate, 10 mM mercaptoethanol, 10% 
DMSO, and 35 mM MOPS (pH 7.2). 
Similarly, the 3’-LTR cDNA sequence (75 ng) of HIV-1.; (+) 5’-ACT GGA AGG GTT AAT 
TTA CTC CAA GCA AAG GCA AGA TAT CC TTG ATT TGT GGG TCT ATA ACA CAC 
AAG GCT ACT TCC CA-3’ and (-) 5’-ACTG GGA AGT AGC CTT GTG TGT TAT AGA 
CCC ACA AAT CAA GGA TAT CTT GCC TTT GCT TGG AGT AAA TTA ACC CTT 
CCAGT-3’, was incubated with the recombinant retroviral integrase. After incubation, the 
double-stranded (ds) 5’-LTR DNA was combined with the ds 3’-LTR DNA for 1 h at 30 °C, 
and the LTR DNA was then further incubated with the target DNA for 1 h at 30°C. As 
controls, ds 5’-LTR DNA and ds 3’-LTR DNA were also individually incubated with the 
target DNA. For control target DNAs we synthesized four random 144-bp sequences, which 
were designed by a random number generator, and we ligated these sequences into circular 
DNA in the same manner as described below for the target DNA 
In order to prevent non-specific reactions at the target DNA sequence, we ligated the 
target sequence DNA into circular plasmid DNA (Invitrogen pCR2.1 TOPO vector) and 
used this entire DNA as the target DNA for the assay (Fig. 6). The proportion of LTRs and 
target DNAs was optimized to prevent both non-specific reactions and integration due to 
an excess of LTRs. The DNA reacted in the buffer was purified using a QIA quick column 
(QIAGEN, GmbH, Germany). PCR amplification was then performed using retroviral 
primers: the HIV-1 U5’-LTR primer, 5’-GTG TGC CCG TCT GTT GTG TGA CTCTGG-3’, 
or the HIV-1 U3’-LTR primer, 5’-CTG GGA AGT AGC CTT GTG TGT TAT AG-3’, and a 
TOPO vector primer 5’-TCA CTC ATG GTT ATG GCA GC -3’ whose first nucleotide 
corresponds to nucleotide position 2222 in the TOPO-pCR2.1 plasmid (Invitrogen, 
Carlsberg, CA). Amplicon copy number was quantified following identification of the 
HIV-1-substrate DNA junction [14]. 
3. Results 
3.1 Selective viral DNA integration into the target sequence 
Figures 9 and 10 show the percentage of viral DNA integration into the target sequence or 
into the same length random sequences. Four types of the same length random sequences 
were used as controls. The horizontal blue line shows the percentage integration when 
uniform integration into the substrate DNA, including into the target DNA plus the circular 
plasmid, was thought to occur. These data indicate that the percentage of integration into 
the target sequence was significantly higher than that into random sequences. Also, when a 
target sequence was used in which the middle 5’-CA and 5’-GT nucleotides were deleted, 
the integration efficiency was significantly decreased. Thus, local nucleotide motifs within 
the target sequence affect integration efficiency.  
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Fig. 9. Integration into target sequence DNA vs. random sequence DNAs.  
The percentage of PCR product copies derived from viral DNA that had integrated into the 
target sequence or into random sequences is plotted vs. the total number of PCR product 
copies, including the PCR products that were integrated into the remainder of the DNA 
sequence of the plasmid. The horizontal line shows the ratio of these PCR products when 
integration was thought to occur in a uniform manner in the 4-kb substrate DNA. 
 
Fig. 10. A graph of the percentage integration into the target sequence or into random 
sequences.  
The left arrows represents the percentage (~2.3%) of integration into target DNA to 
integration into control when integration was thought to occur in a uniform manner in the 
substrate DNA, the target sequence DNA plus the circular plasmid with which it was 
www.intechopen.com
 Biochemistry 
 
314 
ligated. The integration efficiency was significantly decreased when CA and GT were 
removed from the middle region of the repeat. Thus, local nucleotide motifs affect 
integration efficiency (****P < 0.001). 
3.2 In vitro integration site in the target repeat sequence DNA 
Figure 11 shows the in vitro integration site in the target repeat sequence DNA. The entire 
target sequence is shown in this figure. The vertical axis indicates the percentage of PCR 
amplicons derived from the integration of individual LTR units. Integration efficiency was 
significantly higher when both the 5’- and the 3’-LTR DNA were used than when either LTR 
DNA was used alone. The use of both 5’- and 3’-LTR DNA is one of the unique points of our 
protocol, since previous protocols used a single 3’-LTR DNA (Figs. 7 and 11). 
5'ACTGGAAGGC-----   -----TCTAGCA   3’
3’ACCTTCCG-------   -----AGATCGTCA 5’
                   -----TCTAGCA   3’
                   -----AGATCGTCA 5’
5'ACTGGAAGGC-----   
3’ACCTTCCG-------
HIV-1 LTR DNA 
5’-LTR 3’-LTR
Target DNA 
 
 
Fig. 11. In vitro integration site in the target repeat sequence DNA.  
The vertical axis indicates the percentage of the PCR amplicons derived from proviral DNA 
integrating into individual units. The entire target sequence is shown. The integration 
efficiency was significantly higher when both 5’- and 3’-LTR DNA were used rather than 
when a single LTR DNA was used. The use of both 5’- and 3’-LTR DNA is one of the unique 
points of our protocol. x, GTGGAGGGCAGT; y, ACTGCCCCCAC. (*** P < 0.001) 
Interestingly, we found that the middle segment of the target sequence was more favorable 
for integration, even though the same sequence units were repeated in the target sequence. 
To explain this observation, we considered the possibility that a structural factor may 
contribute to selective integration into the middle segment. Thus, if a single strand of the 
target DNA focally appeared by rewinding of the target double strand DNA, a long hairpin 
or cruciform structure may form in the target sequence site. It is probable that, if the target 
sequence DNA is open, or rewound, then the top of such a secondary structure would be 
favorable for integration. DNA folding thermodynamic analysis was performed to 
determine secondary structure in the target DNA and a hairpin structure was indeed 
predicted by this analysis (Fig. 12). 
www.intechopen.com
 HIV-1 Selectively Integrates Into Host DNA In Vitro 
 
315 
 
Fig. 12. A presumed secondary structure in the target sequence DNA.  
The blue lines in the target DNA sequence shown at the top indicate the most frequent 
integration site. The presumed hairpin like structure shown at the bottom was constructed 
based on calculation of the target DNA sequence using the m-fold program 
(http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form). dG, dH, and dS represent 
Gibbs’ free energy, enthalpy, and entropy in ssDNA, respectively. A box represents the most 
frequent integration site.  
3.2 Decoy effect of modified target sequences 
We prepared two modified DNA target sequences in which the 5’-CA and 5’-GT were 
removed from the repeat unit at the middle site, termed modified sequence I and II, 
respectively (Fig. 13). PCR analysis of in vitro integration into modified sequence I or II 
revealed significant reductions in the number of copies of the PCR products compared to 
integration into the unmodified sequence. In addition, integration selectivity was not 
evident when using the modified DNA sequences (P < 0.05). We next mixed substrate DNA  
 
Fig. 13. Modified target DNA sequences. 
target 
Modified I 
Modified II 
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containing the target sequence with substrate DNA containing modified sequence I or II in 
equal amounts, and examined the number of PCR product copies that originated from 
integration into the non-modified target sequence. Integration into the original, non-
modified target sequence of the substrate DNA was significantly reduced when this DNA 
was mixed with the modified sequences (Fig. 14). 
Two modified DNA sequences were prepared in which CA and GT were removed from the 
repeat unit at the middle site, termed modified sequence I and modified sequence II 
respectively. Red letters represent the TG/CA motifs. Yellow letters represent the GT/AC 
motifs that are observed in the HIV-1 proviral genome. 
 
Fig. 14. In vitro integration using modified sequence I or II  
The result showed significant reductions in the number of copies of PCR products derived 
from integrated DNA. In addition, integration selectivity was evidently suppressed when 
using the modified DNA targets (left graph, *P < 0.05). Substrate DNA containing the 
target sequence was then mixed with substrate DNA containing modified sequence I or II 
in equal amounts, and the percentage of PCR product copies originating from integration 
into the original target sequence were determined. Integration into the original target 
sequence was significantly reduced when this target was mixed with the modified 
sequences (right graph, *P < 0.05). 
3.3 Biochemistry of the integrase: DNA structure fluctuation enhances selective 
integration 
We digested circular DNA with HIV-1 integrase in a buffer containing various 
concentrations of manganese dichloride and measured the band intensity of linearized DNA 
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following electrophoresis. The relative band intensity increased when the concentration of 
MnCl2 in the reaction buffer exceeded 40 mM (Fig. 15). This result raised the question of 
how such fluctuation in DNA structure influences the selectivity of in vitro HIV-1 
integration. Furthermore, the percentage of integration into the target sequence DNA was 
found to increase significantly when the concentration of MnCl2 exceeded 40 mM. The ratio 
of the PCR product number derived from integration into the target sequence DNA was also 
found to increase significantly when the MnCl2 concentration exceeded 40 mM (Fig. 16). In 
conclusion, such fluctuation may generate a favorable conformation of target DNA for 
integration of the HIV-1 LTR [16, 17]. 
 
 
Fig. 15. Effect of MnCl2 concentration and structural-fluctuation of target DNA on 
integration  
(A) Electrophoretogram of plasmid plus target DNA (left) and plasmid DNA (right). P and 
Q indicate structural isomers of the circular DNA. R, a single fragment, indicates the 
digested DNA fragment after 90 min incubation. The vertical axis indicates relative signal 
C 
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intensity and the horizontal axis indicates electrophoretic mobility distance. (B) 
Electrophoresis of the DNA following incubation of recombinant integrase in buffer 
containing 0, 20, or 40 mM MnCl2 following incubation for 0, 50, and 90 min. P, Q, and R are 
as described in (A). Upper and lower photographs display electrophoresis of plasmid plus 
target DNA and plasmid DNA, respectively. Significant fluctuation in R was observed in the 
electrophoresed DNA following 90 min incubation. (C) Relative signal area of the digested 
4.0-kb substrate DNA corresponding to R in (B). Error bars represent standard deviation 
(S.D.). Fragment R area was calculated by integration of the individual curves shown in the 
electrophoretogram (A) with respect to electrophoretic mobility distance. Signal area 
significantly increased when 40 mM MnCl2 was included in the buffer. 
 
Fig. 16. DNA structural fluctuation and integration 
A MnCl2 concentration greater than 40 mM significantly increased the percentage of 
integration into the target sequence DNA. The percentage of copy number of PCR products 
derived from integration into the target sequence DNA was found to increase significantly 
when the concentration of MnCl2 exceeded 40 mM. It is concluded that such fluctuation may 
generate a favorable conformation of target DNA (in red) for integration of HIV-1 LTR DNA. 
4. Conclusion 
In conclusion, selective HIV-1 integration was proved at an in vitro level in this study. The 
factors that determine this selectivity are (i) a sequence motif, including CAGT, and (ii) a 
structural factor that can be induced by fluctuation of a high concentration of MnCl2 [16, 17]. 
The findings shown in Figs. 9 and 10 indicate that the percentage of integration into the 
target sequence was significantly greater than the integration rate into the random and 
deleted sequences. Moreover, the entire repeat sequence or secondary structure may be a 
target of integration. 
In particular, our findings that sequences similar to the target DNA sequence interfere with 
integration (Fig. 14). Thus, a modified DNA can act as a decoy for the target DNA. In the 
present study, integration efficiency and selectivity were highly sensitive to MnCl2 
concentration in the reaction buffer. In particular, the integration efficiency and selectivity 
increased significantly when the MnCl2 concentration was increased from 30 mM to 40 mM. 
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Fluctuations in the electrophoretic mobility of the substrate DNA also increased. These 
results suggest that there is a threshold concentration of MnCl2 for in vitro integration, 
probably because MnCl2 induces instability of secondary structure and therefore phase 
transition of the host DNA strand may occur. Target DNA can probably not generate the 
specified stable conformation under 40mM of MnCl2. Based on these data as well as the data 
shown in Fig. 15, we propose that there are close correlations between structural changes in 
substrate DNA and integration selectivity and efficiency (Fig. 16, 17). We have used MnCl2 
for studies of in vitro integration because this salt is more appropriate than other salts for the 
generation of in vivo integration. However, during in vivo integration into the host genome, 
numerous DNA binding proteins and metal ions regulate the reaction in a complex manner. 
Therefore, the present data cannot be immediately applied to in vivo systems and further 
investigation using cell culture systems are necessary. Nevertheless, this in vitro integration 
assay is expected to facilitate understanding of the pathogenicity of HIV-1. 
 
Fig. 17. A model of integration 
The top of the secondary structure may be favorable for integration when the target DNA 
sequence is open or rewound by protein binding to the upstream of the target DNA 
sequence. 
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